Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder
- PMID: 29681025
- DOI: 10.1007/s12035-018-1051-7
Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder
Abstract
Accumulating evidence indicates that oxidative and nitrosative stress (O&NS) pathways play a key role in the pathophysiology of bipolar disorder (BD) and major depressive disorder (MDD). However, only a handful of studies have directly compared alterations in O&NS pathways among patients with MDD and BD types I (BPI) and BPII. Thus, the current study compared superoxide dismutase (SOD1), lipid hydroperoxides (LOOH), catalase, nitric oxide metabolites (NOx), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) between mood disorder patients in a clinically remitted state. To this end 45, 23, and 37 participants with BPI, BPII, and MDD, respectively, as well as 54 healthy controls (HCs) were recruited. Z-unit weighted composite scores were computed as indices of reactive oxygen species (ROS) production and nitro-oxidative stress driving lipid or protein oxidation. SOD1, NOx, and MDA were significantly higher in MDD than in the other three groups. AOPP was significantly higher in BPI than in HCs and BPII patients. BPII patients showed lower SOD1 compared to all other groups. Furthermore, MDD was characterized by increased indices of ROS and lipid hydroperoxide production compared to BPI and BPII groups. Indices of nitro-oxidative stress coupled with aldehyde production or protein oxidation were significantly different among the three patient groups (BDII > BDI > MDD). Finally, depressive symptom scores were significantly associated with higher LOOH and AOPP levels. In conclusion, depression is accompanied by increased ROS production, which is insufficiently dampened by catalase activity, thereby increasing nitro-oxidative damage to lipids and aldehyde production. Increased protein oxidation with formation of AOPP appeared to be hallmark of MDD and BPI. In addition, patients with BPII may have protection against the damaging effects of ROS including lipid peroxidation and aldehyde formation. This study suggests that biomarkers related to O&NS could aid in the differentiation of MDD, BPI, and BPII.
Keywords: Bipolar disorder; Depression; Immune; Inflammation; Oxidative and nitrosative stress.
Similar articles
-
Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.Neurotox Res. 2018 Oct;34(3):489-510. doi: 10.1007/s12640-018-9906-2. Epub 2018 May 7. Neurotox Res. 2018. PMID: 29736827
-
In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life.Metab Brain Dis. 2018 Aug;33(4):1081-1096. doi: 10.1007/s11011-018-0209-3. Epub 2018 Mar 14. Metab Brain Dis. 2018. PMID: 29542039
-
Increased nitro-oxidative stress toxicity as a major determinant of increased blood pressure in mood disorders.J Affect Disord. 2021 Jan 1;278:226-238. doi: 10.1016/j.jad.2020.09.040. Epub 2020 Sep 14. J Affect Disord. 2021. PMID: 32971315
-
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):676-92. doi: 10.1016/j.pnpbp.2010.05.004. Epub 2010 May 12. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20471444 Review.
-
Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:34-50. doi: 10.1016/j.pnpbp.2017.04.027. Epub 2017 Apr 22. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 28438472 Review.
Cited by
-
Role of adenosine in the pathophysiology and treatment of attention deficit hyperactivity disorder.Purinergic Signal. 2024 Oct 31. doi: 10.1007/s11302-024-10059-2. Online ahead of print. Purinergic Signal. 2024. PMID: 39480600
-
Oxidative Stress Markers and Antioxidant Enzymes in Children and Adolescents with Depressive Disorder and Impact of Omega-3 Fatty Acids in Randomised Clinical Trial.Antioxidants (Basel). 2021 Aug 5;10(8):1256. doi: 10.3390/antiox10081256. Antioxidants (Basel). 2021. PMID: 34439504 Free PMC article.
-
Association between arginine catabolism and major depressive disorder: A protocol for the systematic review and meta-analysis of metabolic pathway.Medicine (Baltimore). 2020 Jul 2;99(27):e21068. doi: 10.1097/MD.0000000000021068. Medicine (Baltimore). 2020. PMID: 32629736 Free PMC article.
-
Major depressive disorder: hypothesis, mechanism, prevention and treatment.Signal Transduct Target Ther. 2024 Feb 9;9(1):30. doi: 10.1038/s41392-024-01738-y. Signal Transduct Target Ther. 2024. PMID: 38331979 Free PMC article. Review.
-
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection.J Clin Med. 2023 Jan 8;12(2):511. doi: 10.3390/jcm12020511. J Clin Med. 2023. PMID: 36675440 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous